Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Business, Policy & Funding › Business News › ArcDia Inks Central European Distribution Deal for Point-of-Care Testing Platform, Assays

ArcDia Inks Central European Distribution Deal for Point-of-Care Testing Platform, Assays

Sep 10, 2020
|
staff reporter

NEW YORK — Finnish infectious disease testing firm ArcDia International said on Thursday that it has signed a Central European distribution deal for its automated MariPOC point-of-care testing platform and related infectious diseases immunoassays with Hain Lifescience.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Feb
23
Featured Webinar

After the Surge: Driving Sample Processing Efficiency of Coronavirus Samples

Sponsored by
Thermo Fisher Scientific

As the world continues to contend with coronavirus and a surge in the infection rate, labs are required to run more samples than ever before. 

What's Popular?

In Infectious Disease

  1. Infectious Disease Test Firm Talis Biomedical Files for IPO

  2. Fluxergy Aiming to Provide Low-Cost, Multimodal Testing for SARS-CoV-2, Other Disease Targets

    Premium

  3. Lab Stakeholders Welcome Biden Moves on COVID-19 Testing, Suggest Additional Steps

    Premium

  4. Rhinostics Licenses Procter & Gamble Nasal Swab for COVID-19 Testing

  5. Ambry Genetics Gets FDA Emergency Use Authorization for Coronavirus Test

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2021 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.